| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 145, 1399-1410, Copyright © 1994 by American Society for Investigative Pathology
REGULAR ARTICLES |
GF Pierce, JE Tarpley, RM Allman, PS Goode, CM Serdar, B Morris, TA Mustoe and J Vande Berg
Department of Experimental Pathology, Amgen Inc., Thousand Oaks, California.
Cellular and molecular mechanisms responsible for the observed vulnerary effects of recombinant human platelet-derived growth factor BB (rP-DGF-BB) in man have not been elucidated. In a double-blinded trial, patients having chronic pressure ulcers were treated topically with either rPDGF-BB or placebo for 28 days. To explore how rPDGF-BB may induce chronic wounds to heal, biopsies were taken from the ulcers of a cohort of 20 patients from the trial and evaluated in a blinded fashion by light microscopy for 1), fibroblast content, 2) neovessel formation, and 3), collagen deposition. Electron microscopy also was used to assess fibroblast activation and collagen deposition. Before initiation of therapy most wounds had few fibroblasts and most of those present were not activated. When mean scores for the total active treatment phase (days 8, 15, and 29) for rPDGF-BB-treated ulcers were compared with the scores for placebo-treated ulcers, fibroblast content was significantly higher for the rPDGF-BB-treated ulcers (P = 0.03, Kruskal-Wallis test). More significant differences in fibroblast and neovessel content were observed when six nonhealing wounds were eliminated from the analysis (three placebo, three treatment). Thus, in all healing wounds, rPDGF-BB therapy significantly increased fibroblast (P = 0.0007) and neovessel (P = 0.02) content. These results were correlated with increased collagen fibrillogenesis by fibroblasts from healing rPDGF-BB-treated wounds, as assessed by intracellular procollagen type I immunostaining, and by electron microscopy, and were concordant with clinical measurements (eg, area of ulcer opening and ulcer volume) which showed greater healing in rPDGF-BB-treated wounds. These results suggest induction of fibroblast proliferation and differentiation is one mechanism by which rPDGF-BB can accelerate wound healing and that rPDGF-BB can augment healing responses within a majority of, but not all, nonhealing chronic pressure ulcers in man.
This article has been cited by other articles:
 |
|
 |
|
  J. Andrae, R. Gallini, and C. Betsholtz Role of platelet-derived growth factors in physiology and medicine Genes & Dev., May 15, 2008; 22(10): 1276 - 1312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Li, J. Fan, M. Chen, S. Guan, D. Sawcer, G. M. Bokoch, and D. T. Woodley Mechanism of Human Dermal Fibroblast Migration Driven by Type I Collagen and Platelet-derived Growth Factor-BB Mol. Biol. Cell, January 1, 2004; 15(1): 294 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Thomas The Promise of Topical Growth Factors in Healing Pressure Ulcers Ann Intern Med, October 21, 2003; 139(8): 694 - 695. [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Pierce Inflammation in Nonhealing Diabetic Wounds : The Space-Time Continuum Does Matter Am. J. Pathol., August 1, 2001; 159(2): 399 - 403. [Full Text]
|
|
|
|
 |
|
 C.-H. Heldin and B. Westermark Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor Physiol Rev, October 1, 1999; 79(4): 1283 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Chen, L. Zhao, M. Bamat, R. von Borstel, and T. Mustoe Acceleration of Wound Healing With Topically Applied Deoxyribonucleosides Arch Surg, May 1, 1999; 134(5): 520 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Hildebrand, S. L-Y. Woo, D. W. Smith, C. R. Allen, M. Deie, B. J. Taylor, and C. C. Schmidt The Effects of Platelet-Derived Growth Factor-BB on Healing of the Rabbit Medial Collateral Ligament: An In Vivo Study Am. J. Sports Med., July 1, 1998; 26(4): 549 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Warshamana, S. Martinez, J. A. Lasky, M. Corti, and A. R. Brody Dexamethasone activates expression of the PDGF-alpha receptor and induces lung fibroblast proliferation Am J Physiol Lung Cell Mol Physiol, April 1, 1998; 274(4): L499 - L507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-Y. Liu, G. F. Morris, W.-H. Lei, C. E. Hart, J. A. Lasky, and A. R. Brody Rapid Activation of PDGF-A and -B Expression at Sites of Lung Injury in Asbestos-exposed Rats Am. J. Respir. Cell Mol. Biol., August 1, 1997; 17(2): 129 - 140. [Abstract] [Full Text]
|
|
|
|
|
|
L Guo, L Degenstein, and E Fuchs Keratinocyte growth factor is required for hair development but not for wound healing. Genes & Dev., January 15, 1996; 10(2): 165 - 175. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
